HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald C Sheppard Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

1/2020Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald C Sheppard Research Topics

Disease

21Infections
01/2022 - 07/2004
10Aspergillosis
10/2021 - 04/2004
5Invasive Fungal Infections
01/2022 - 08/2005
5Invasive Pulmonary Aspergillosis
01/2022 - 01/2009
4Pulmonary Aspergillosis
01/2022 - 07/2015
4Mycoses (Diseases, Fungus)
01/2022 - 04/2016
4Inflammation (Inflammations)
01/2021 - 01/2016
4Candidiasis (Moniliasis)
04/2016 - 04/2005
2Candidemia
01/2022 - 09/2021
2Neutropenia
01/2022 - 08/2008
2HIV Infections (HIV Infection)
01/2020 - 04/2006
2Cryptococcosis
04/2019 - 01/2017
2autosomal recessive Candidiasis familial chronic mucocutaneous
04/2016 - 07/2014
2Hematologic Neoplasms (Hematological Malignancy)
10/2010 - 05/2010
2Autoimmune Diseases (Autoimmune Disease)
05/2010 - 08/2005
1Cross Infection (Nosocomial Infection)
12/2021
1Coinfection
10/2021
1Invasive Candidiasis
09/2021
1Atherosclerosis
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Vascular Diseases (Vascular Disease)
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Disease Progression
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Thrombosis (Thrombus)
01/2020
1Neoplasms (Cancer)
01/2020
1Starvation
12/2019
1Mucormycosis
11/2019
1Leukemia
01/2017
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2016
1Lymphoma (Lymphomas)
04/2016
1Hallucinations (Hallucination)
02/2016
1Chronic Granulomatous Disease
01/2016

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
01/2021 - 08/2008
4EchinocandinsIBA
01/2022 - 04/2006
4posaconazoleFDA Link
10/2021 - 02/2016
3Glycoside Hydrolases (Endoglycosidases)IBA
12/2021 - 01/2018
3Voriconazole (Vfend)FDA LinkGeneric
09/2021 - 05/2010
3galactosaminogalactanIBA
12/2019 - 01/2013
3liposomal amphotericin BFDA Link
11/2019 - 10/2006
3Proteins (Proteins, Gene)FDA Link
04/2016 - 07/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2009 - 08/2005
2EnzymesIBA
12/2021 - 01/2018
2Antifungal AgentsIBA
10/2021 - 01/2021
2AzolesIBA
09/2021 - 07/2015
2Polysaccharides (Glycans)IBA
01/2021 - 08/2017
2Caspofungin (Cancidas)FDA Link
11/2020 - 05/2010
2Fungal PolysaccharidesIBA
01/2020 - 08/2017
2MycotoxinsIBA
01/2020 - 08/2008
2Transcription Factors (Transcription Factor)IBA
12/2019 - 11/2010
2galactomannanIBA
04/2019 - 10/2010
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2016 - 07/2014
2Micafungin (FK463)FDA Link
07/2015 - 04/2006
2Virulence Factors (Pathogenicity Factors)IBA
01/2013 - 08/2008
2E-SelectinIBA
01/2009 - 08/2008
2Interleukin-8 (Interleukin 8)IBA
01/2009 - 08/2008
1guanosine 5'-monophosphorothioateIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1TriazolesIBA
09/2021
1Fluconazole (Zonal)FDA LinkGeneric
09/2021
1Amphotericin B (Amphotericin)FDA LinkGeneric
09/2021
1lipoxin A4IBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1ApolipoproteinsIBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1CholesterolIBA
01/2021
1GlycolipidsIBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Interleukin-1 (Interleukin 1)IBA
01/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1Neuraminidase (Sialidase)IBA
01/2021
1LDL Receptors (LDL Receptor)IBA
01/2021
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2021
1Asialoglycoprotein ReceptorIBA
01/2021
1Apolipoprotein B-100 (Apo B 100)IBA
01/2021
1AnaphylatoxinsIBA
01/2020
1Galectin 3 (LGALS3)IBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Fungal AntigensIBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1IronIBA
12/2019
1galactoxylomannanIBA
04/2019
1Pharmaceutical PreparationsIBA
04/2019
1SolutionsIBA
01/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2017
1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2017
1Interleukin-1 Type I ReceptorsIBA
01/2017
1ras-GRF1 (ras GRF1)IBA
04/2016
1ChemokinesIBA
09/2015
1Interleukin-17 (Interleukin 17)IBA
09/2015

Therapy/Procedure

8Therapeutics
01/2022 - 07/2014
2Catheters
12/2021 - 07/2008
1Central Venous Catheters
12/2021
1Art Therapy
01/2020
1Lasers (Laser)
04/2019
1Aftercare (After-Treatment)
04/2019
1Stem Cell Transplantation
11/2016